ImageneBio, Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | 100.0% | – | – | – | – | – | – | |
| 212.7% | 244.6% | 206.1% | 255.1% | 36,003.1% | 288.5% | 320.5% | 357.0% | 61.0% | 423.8% | 4,054.5% | 294.4% | 287.0% | 292.7% | 708.0% | 20.4% | 46.3% | – | – | 194.8% | – | 464.4% | – | – | – | – | – | – | |
| -112.7% | -144.6% | -106.1% | -155.1% | -35,903.1% | -188.5% | -220.5% | -257.0% | 39.0% | -323.8% | -3,954.5% | -194.4% | -187.0% | -192.7% | -608.0% | 79.6% | 53.7% | – | – | -194.8% | – | 100.0% | – | – | – | – | – | – | |
| 212.7% | 244.6% | 206.1% | 255.1% | 36,003.1% | 288.5% | 320.5% | 357.0% | 61.0% | 423.8% | 4,054.5% | 294.4% | 287.0% | 292.7% | 757.1% | 100.0% | 2,119.7% | – | – | 194.8% | – | 505.0% | – | – | – | – | – | – | |
| 81.4% | 77.8% | 58.5% | 65.2% | 4,178.5% | 91.3% | 137.0% | 130.6% | 25.2% | 177.4% | 1,530.1% | 84.8% | 90.4% | 99.3% | 265.6% | 509.2% | 1,258.4% | – | – | 136.5% | – | 344.4% | – | – | – | – | – | – | |
| 81.4% | 77.8% | 58.5% | 65.2% | 4,178.5% | 91.3% | 137.0% | 130.6% | 25.2% | 177.4% | 1,530.1% | 84.8% | 90.4% | 99.3% | 314.7% | 1,725.4% | 3,378.1% | – | – | 159.7% | – | 849.4% | – | – | – | – | – | – | |
| -194.1% | -222.4% | -164.6% | -220.3% | -40,081.5% | -279.8% | -357.5% | -387.7% | 13.8% | -501.2% | -5,484.6% | -279.2% | -277.3% | -292.0% | -922.7% | -1,645.8% | -3,324.4% | – | – | -354.5% | – | -749.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 64.7% | – | 196.7% | – | – | – | – | – | – | – | – | – | – | – | |
| -182.2% | -215.2% | -163.9% | -219.9% | -40,078.5% | -279.7% | -357.3% | -387.5% | 13.8% | -497.6% | -5,364.1% | -270.8% | -258.7% | -267.6% | -854.0% | -1,463.5% | -2,981.9% | – | – | -292.1% | – | -759.6% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -3.6% | -120.4% | -8.4% | -18.7% | – | – | – | -24.6% | – | – | 0.3% | – | 3.5% | – | – | – | – | – | – | |
| -182.2% | -215.2% | -163.9% | -219.9% | -40,078.5% | -279.7% | -357.3% | -387.5% | 13.8% | -497.6% | -5,364.1% | -270.8% | -258.7% | -267.6% | -854.0% | -1,463.5% | -2,957.4% | – | – | -292.4% | – | -759.6% | – | – | – | – | – | – | |
| -191.8% | -220.1% | -162.2% | -217.7% | -39,966.2% | -277.2% | -353.2% | -383.6% | 14.6% | -492.3% | -5,325.4% | -267.5% | -254.8% | -263.3% | -842.0% | -1,443.1% | -2,739.0% | – | – | -328.7% | – | -739.4% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.